Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Anthocyanins, a group of flavonoid compounds responsible for the red, purple, and blue colors in many fruits and vegetables (such as blueberries, blackberries, and red cabbage), have garnered scientific interest for their potential to support the management of Inflammatory Bowel Disorders (IBD), including Crohn’s disease and ulcerative colitis. Several preclinical studies in cell cultures and animal models indicate that anthocyanins may exert anti-inflammatory effects by modulating cytokine production, inhibiting oxidative stress, and supporting the maintenance of intestinal barrier function. For instance, research has shown that anthocyanin-rich extracts can reduce colonic inflammation and tissue damage in rodents with experimentally induced colitis. These effects are thought to be mediated through the downregulation of inflammatory pathways such as NF-κB and the upregulation of antioxidant defenses.

However, while these mechanistic and animal studies are promising, high-quality clinical trials in humans remain limited. Some small human studies suggest potential benefits, such as reduced inflammatory markers in patients with ulcerative colitis consuming anthocyanin-rich foods, but results are not yet definitive. As a result, while there is a scientific rationale and some preliminary evidence for the use of anthocyanins in supporting IBD management, the overall quality and quantity of clinical evidence is currently modest, justifying a score of 2/5. Further well-designed, large-scale human studies are needed to confirm efficacy and establish clear therapeutic recommendations.

More about anthocyanins
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by anthocyanins

Products containing anthocyanins